The invention relates to substituted 2-alkylamino-3-(arylsulfonyl)cycloalkyl[e or d]pyrazolo[1,5-a]pyrimidines, to serotonin 5-HT6 receptor antagonists, to novel drug substances and pharmaceutical compositions comprising the said compounds as active ingredients, and to novel medicaments and method for treatment and prophylaxis of various CNS diseases.
2-Alkylamino-3-arylsulfonylcycloalkyl[e]pyrazolo[1,5-a]pyrimidines of general formula 1 and 2-alkylamino-3-arylsulfonylcycloalkyl[d]pyrazolo[1,5-a]pyrimidines of general formula 2,
wherein: R1 is hydrogen or C1-C3 alkyl; R2 is C1-C3 alkyl; R3 is hydrogen, one or more optionally identical halogen atoms, C1-C3 alkyl or hydroxyl group optionally substituted with C1-C3 alkyl; n is the whole numbers 1, 2 or 3.
本发明涉及取代的2-烷基
氨基-3-(芳基磺酰基)
环烷基[e或d]
吡唑并[1,5-a]
嘧啶、5-羟
色胺5-HT6受体
拮抗剂、以上述化合物为活性成分的新型药物物质和药物组合物,以及治疗和预防各种中枢神经系统疾病的新型药物和方法。
通式 1 的 2-烷基
氨基-3-芳基磺酰基
环烷基[e]
吡唑并[1,5-a]
嘧啶和通式 2 的 2-烷基
氨基-3-芳基磺酰基
环烷基[d]
吡唑并[1,5-a]
嘧啶、
其中R1 是
氢或 C1-C3 烷基;R2 是 C1-C3 烷基;R3 是
氢、一个或多个任选相同的卤素原子、C1-C3 烷基或任选被 C1-C3 烷基取代的羟基;n 是整数 1、2 或 3。